RTW Investments’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-772,735
Closed -$3.65M 94
2022
Q2
$3.65M Buy
772,735
+573,168
+287% +$2.82M 0.09% 82
2022
Q1
$1.4M Sell
199,567
-75,433
-27% -$515K 0.03% 93
2021
Q4
$2.8M Hold
275,000
0.04% 104
2021
Q3
$3.36M Buy
+275,000
New +$4.15M 0.05% 102

Other funds holding MXCT

RTW Investments's MXCT Position: Q3 2022 in Review

RTW Investments sold out of MaxCyte (MXCT) in Q3 2022, closing a stake of 772,735 shares — an estimated $3.65M sold.

RTW Investments first reported a position in MXCT in Q3 2021 and held it in 4 quarters. The position peaked at $3.65M in Q2 2022. 108 funds tracked by Wall St. Rank hold MXCT as of Q3 2022.

  • RTW Investments reported no remaining MaxCyte position as of Q3 2022 after selling out during the quarter.
  • RTW Investments sold 772,735 MaxCyte shares in Q3 2022, an estimated $3.65M.
  • RTW Investments first reported a position in MaxCyte in Q3 2021 and held it in 4 quarters.
  • RTW Investments's MaxCyte position peaked at $3.65M in Q2 2022.
  • 108 funds tracked by Wall St. Rank held MaxCyte as of Q3 2022.

Based on RTW Investments's 13F filing for Q3 2022, filed 14 Nov 2022.